BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27349446)

  • 1. Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays.
    Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Maciejewski H; Voit B; Kaczmarek A; Robak T; Klajnert-Maculewicz B; Cebula-Obrzut B; Smolewski P; Borowiec M; Bryszewska M
    Anticancer Agents Med Chem; 2017; 17(1):102-114. PubMed ID: 27349446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway.
    Franiak-Pietryga I; Maciejewski H; Ostrowska K; Appelhans D; Voit B; Misiewicz M; Kowalczyk P; Bryszewska M; Borowiec M
    Int J Biol Macromol; 2016 Jul; 88():156-61. PubMed ID: 26987432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.
    Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Voit B; Szewczyk M; Góra-Tybor J; Robak T; Klajnert B; Bryszewska M
    Mol Pharm; 2013 Jun; 10(6):2490-501. PubMed ID: 23641871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells.
    Franiak-Pietryga I; Ostrowska K; Maciejewski H; Appelhans D; Misiewicz M; Ziemba B; Bednarek M; Bryszewska M; Borowiec M
    Macromol Biosci; 2017 May; 17(5):. PubMed ID: 27996200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Tumour Activity of Glycodendrimer Nanoparticles in a Subcutaneous MEC-1 Xenograft Model of Human Chronic Lymphocytic Leukemia.
    Ziemba B; Sikorska H; Jander M; Kuncman W; Danilewicz M; Appelhans D; Bryszewska M; Borowiec M; Franiak-Pietryga I
    Anticancer Agents Med Chem; 2020; 20(3):325-334. PubMed ID: 31738155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
    Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
    Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affecting NF-κB cell signaling pathway in chronic lymphocytic leukemia by dendrimers-based nanoparticles.
    Franiak-Pietryga I; Ostrowska K; Maciejewski H; Ziemba B; Appelhans D; Voit B; Jander M; Treliński J; Bryszewska M; Borowiec M
    Toxicol Appl Pharmacol; 2018 Oct; 357():33-38. PubMed ID: 30125597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockage of Wnt/β-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study.
    Franiak-Pietryga I; Maciejewski H; Ziemba B; Appelhans D; Voit B; Robak T; Jander M; Treliński J; Bryszewska M; Borowiec M
    Macromol Biosci; 2017 Nov; 17(11):. PubMed ID: 28762636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.
    Franiak-Pietryga I; Ziemba B; Sikorska H; Jander M; Kuncman W; Danilewicz M; Appelhans D; Lewkowicz P; Ostrowska K; Bryszewska M; Borowiec M
    Toxicol Appl Pharmacol; 2020 Sep; 403():115139. PubMed ID: 32687837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of fourth generation poly(propyleneimine) dendrimers on blood cells.
    Ziemba B; Halets I; Shcharbin D; Appelhans D; Voit B; Pieszynski I; Bryszewska M; Klajnert B
    J Biomed Mater Res A; 2012 Nov; 100(11):2870-80. PubMed ID: 22623362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia.
    Olsson A; Norberg M; Okvist A; Derkow K; Choudhury A; Tobin G; Celsing F; Osterborg A; Rosenquist R; Jondal M; Osorio LM
    Br J Cancer; 2007 Sep; 97(6):769-77. PubMed ID: 17726463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of Nitroxide-Conjugated and Non-Conjugated Glycodendrimers with Normal and Cancer Cells and Biocompatibility Studies.
    Andreozzi E; Antonelli A; Cangiotti M; Canonico B; Sfara C; Pianetti A; Bruscolini F; Sahre K; Appelhans D; Papa S; Ottaviani MF
    Bioconjug Chem; 2017 Feb; 28(2):524-538. PubMed ID: 28068077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target.
    Hegde GV; Peterson KJ; Emanuel K; Mittal AK; Joshi AD; Dickinson JD; Kollessery GJ; Bociek RG; Bierman P; Vose JM; Weisenburger DD; Joshi SS
    Mol Cancer Res; 2008 Dec; 6(12):1928-36. PubMed ID: 19074837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
    Ganeshaguru K; Wickremasinghe RG; Jones DT; Gordon M; Hart SM; Virchis AE; Prentice HG; Hoffbrand AV; Man A; Champain K; Csermak K; Mehta AB
    Haematologica; 2002 Feb; 87(2):167-76. PubMed ID: 11836167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells.
    Horie R; Watanabe M; Okamura T; Taira M; Shoda M; Motoji T; Utsunomiya A; Watanabe T; Higashihara M; Umezawa K
    Leukemia; 2006 May; 20(5):800-6. PubMed ID: 16525497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of minichromosome maintenance 7 expression sensitizes chronic lymphocytic leukemia cells to fludarabine.
    Xu Y; Zhou X; Li Y; Zhang Y; Wang X
    Leuk Lymphoma; 2019 May; 60(5):1266-1274. PubMed ID: 30714848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect.
    Martinez-Lostao L; Briones J; Martinez-Gallo M; Forné I; Sierra J; Rodriguez-Sanchez JL; Juarez C
    Leuk Lymphoma; 2004 Nov; 45(11):2307-14. PubMed ID: 15512822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dense shell glycodendrimers as potential nontoxic anti-amyloidogenic agents in Alzheimer's disease. Amyloid-dendrimer aggregates morphology and cell toxicity.
    Klementieva O; Benseny-Cases N; Gella A; Appelhans D; Voit B; Cladera J
    Biomacromolecules; 2011 Nov; 12(11):3903-9. PubMed ID: 21936579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
    Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
    Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemia.
    Podhorecka M; Klimek P; Chocholska S; Szymczyk A; Macheta A; Kowal M; Dmoszynska A; Hus M
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1121-7. PubMed ID: 26141594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.